Daniel Eyman

Dan serves as President of Meld, a consulting and valuation firm for early stage and venture backed companies. Prior positions include Finance Manager at Nanostring Technologies, Senior Associate at Quist Valuation, Senior Analyst at Pitchbook Data, and Research Scientist at the University of Washington’s Department of Medicine. He has valued more than $80 billion in venture backed companies, assisted founders and companies in raising venture capital, and overseen financial operations for companies. Additionally, Mr. Eyman has authored and co-authored eight scientific papers, which were published in peer-reviewed scientific journals, read throughout the world. Dan holds a Bachelor of Science in Molecular Biology from the University of Washington and a MBA from Seattle University.